BIO Operating Cash Flow

Bio-Rad Laboratories, Inc. Class A Common Stock · Operating Cash Flow

BIO logo

BIO Operating Cash Flow

Latest reported$492.60M
BIO TTM Operating Cash Flow ($12.10M → $492.60M)
High-resolution chart · PNG

BIO operating cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Operating Cash Flow — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (USD)
492,600,000
510,400,000
532,200,000
491,452,000
534,162,000
515,308,000
455,200,000
412,095,000
346,196,000
346,616,000
374,943,000
384,316,000
297,632,000
252,835,000
205,210,000
272,714,000
492,050,000
593,405,000
656,521,000
783,331,000
688,632,000
626,130,000
575,328,000
450,396,000
414,482,000
477,762,000
457,897,000
403,104,000
365,631,000
288,091,000
285,494,000
249,839,000
216,037,000
200,675,000
104,126,000
129,891,000
153,023,000
167,678,000
216,433,000
157,266,000
187,938,000
149,316,000
186,210,000
190,474,000
198,849,000
237,188,000
273,312,000
306,537,000
270,715,000
213,580,000
172,027,000
197,240,000
213,750,000
267,655,000
278,898,000
258,821,000
238,637,000
275,294,000
259,816,000
281,627,000
297,335,000
223,422,000
225,909,000
241,243,000
271,866,000
340,972,000
325,074,000
287,693,000
236,323,000
199,919,000
191,371,000
216,181,000
225,060,000
202,044,000
191,580,000
143,292,000
140,168,000
147,659,000
118,229,000
112,759,000
91,958,000
41,330,000
108,284,000
109,921,000
103,367,000
120,670,000
123,093,000
110,139,000
128,592,000
133,226,000
127,640,000
124,249,000
113,457,000
108,419,000
104,835,000
110,562,000
100,466,000
115,416,000
99,495,000
64,965,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.